Economic evaluation of extended panel analysis in cancer patients with historical NHS diagnostic germline genetic testing – A modeling study based on real-world data
-
Published:2024-12
Issue:
Volume:72
Page:104969
-
ISSN:1769-7212
-
Container-title:European Journal of Medical Genetics
-
language:en
-
Short-container-title:European Journal of Medical Genetics
Author:
Xi QinORCID,
Patel Rahul,
Linton-Willoughby Thomas,
Short John,
Tischkowitz Marc,
Snape Katie,
Morris Stephen
Reference16 articles.
1. Breast cancer risk genes - association analysis in more than 113,000 women;Breast Cancer Association;N. Engl. J. Med.,2021
2. Cancer Research UK. Cancer Mortality Statistics.
3. Congenica,2021
4. Germline mutation prevalence in individuals with pancreatic cancer and a history of previous malignancy;Dudley;Cancer,2018
5. Cost-effectiveness of population-based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 mutation testing in unselected general population women;Manchanda;J. Natl. Cancer Inst.,2018